{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 396,
  "pageCount": 415,
  "prevPage": 395,
  "nextPage": 397,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses direct quotes from a pediatric endocrinologist to undermine the company's commercial narrative.",
  "elementsJson": [
    "paragraph",
    "quote_block"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/396",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-396",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The physician speculated that Soleno wasn’t expecting FDA approval and seems to be lacking a commercial, field rep presence",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2b7-ce4b014ba6aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.42,
        "w": 0.86,
        "x": 0.07,
        "y": 0.52
      },
      "kind": "list",
      "text": "Disinterested in scheduling time with Soleno rep; unclear if Soleno has staff to launch Vykat. Almost no patient or physician enthusiasm.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7fef3b59-7481-4510-92d6-80d1df958bc7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "paragraph",
      "text": "The center’s lack of interest in meeting the Soleno rep was striking – “I don’t see that scheduled in any near future, to be honest with you” – and expressed surprise that diazoxide was even studied for PWS...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f5bab6ed-c7ea-4630-8400-83ed8b68f5f2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“I don’t see that scheduled in any near future, to be honest with you” — Pediatric endocrinologist. “I’m not sure if they have field people...and help and explain...we are not going to proactively reach out to our patient population.” — Pediatric endocrinologist. “Only one family came forward from our division. There was not a big push.” — Pediatric endocrinologist. “Pretty quiet. Some people were quite surprised within our division...it came actually as a surprise that this drug is in a trial. But prior to FDA approval, there was not much noise about it.” — Pediatric endocrinologist.",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2b7-d17e0adc767b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.25,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "62cbd355-963b-45dc-abf1-eb1093c79216",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "3d3bc0e9-8957-423e-bf48-f05e69434e92",
      "evidence": "The slide uses expert testimony to contradict the company's implied commercial readiness.",
      "confidence": 0.85
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}